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ATP in airway surface liquid (ASL) controls mucociliary clearance
functions via the activationof airway epithelial purinergic receptors.
However, abnormally elevated ATP levels have been reported in
inflamed airways, suggesting that excessive ATP in ASL contributes
to airway inflammation. Despite these observations, little is known
about the mechanisms of ATP accumulation in the ASL covering
inflamed airways. In this study, links between cystic fibrosis (CF)–
associated airway inflammation and airway epithelial ATP release
were investigated. Primary human bronchial epithelial (HBE) cells
isolated from CF lungs exhibited enhanced IL-8 secretion after 6 to
11days, but not 28 to 35days, in culture, comparedwithnormalHBE
cells.Hypotonic cell swelling–promotedATPreleasewas increased in
6- to 11-day-old CF HBE cells compared with non-CF HBE cells, but
returnedtonormalvaluesafter28 to35days inculture.Theexposure
of non-CF HBE cells to airway secretions isolated from CF lungs,
namely, sterile supernatants of mucopurulent material (SMM), also
caused enhanced IL-8 secretion and increased ATP release. The
SMM-induced increase inATP releasewas sensitive toCa21 chelation
and vesicle trafficking/exocytosis inhibitors, but not to pannexin
inhibition. Transcript levels of the vesicular nucleotide transporter,
but not pannexin 1, were up-regulated after SMM exposure. SMM-
treated cultures displayed increased basal mucin secretion, but mu-
cin secretion was not enhanced in response to hypotonic challenge
after the exposure of cells to either vehicle or SMM.Wepropose that
CFairway inflammationup-regulates the capacityof airwayepithelia
to release ATP via Ca21-dependent vesicular mechanisms not asso-
ciated with mucin granule secretion.
Keywords: human bronchial epithelia; supernatant of mucopurulent
material from human CF airways; high performance liquid chromatog-
raphy; well-differentiated vesicular nucleotide transporter
Abnormal ion transport results in mucous dehydration and poor
clearance, which produce lung disease in cystic fibrosis (CF). Mu-
cous dehydration also contributes to the progressive airway obstruc-
tion associated with chronic obstructive lung disease (COPD) (1).
ATP and other nucleotides present in the airway surface liquid
(ASL) are important modulators of the ion transport activities
that regulate mucous hydration and mucociliary clearance
(MCC) via the activation of airway epithelial cell purinergic
receptors (2). However, purinergic receptors are also abundantly
expressed in neutrophils, monocytes/macrophages, lymphocytes,
and other immunocompetent cells (3). Therefore, fine control mech-
anisms are required in the lung to establish local nucleotide/
nucleoside concentrations that maintain MCC activities (4, 5)
without promoting the recruitment and/or activation of inflam-
matory cells. Indeed, recent studies indicate that abnormally
high levels of nucleotides in lung secretions are correlated with
COPD severity, asthma, and CF-associated neutrophilic inflam-
mation (6–18), suggesting that the dysregulation of nucleotide
release and/or metabolism rates is a feature of inflamed lungs.
Airway epithelial cells normally release ATP and other nucleo-
tides in response to cell swelling, shear and compressive stress, and
other physiological stimuli, via conductive and vesicular pathways
(5, 19–23). However, studies investigating the mechanisms under-
lying pathologically elevated airway epithelial ATP release have
just begun. For example, primary cultures of normal airway epi-
thelial cells that were induced to develop mucous (goblet) cell
hyperplasia via respiratory syncytial virus (RSV) infection or
IL-13 exposure exhibited an enhanced release of nucleotides,
which was correlated with increased mucin secretion (24). How-
ever, the cellular sources and mechanisms of enhanced ATP
release in lungs chronically inflamed by nonallergic mechanisms
(e.g., chronic bacterial infections associated with CF) have not
been identified.
In the present study, we used early-stage primary cultures of
CF human bronchial epithelia (HBEs) that retain hyperinflamma-
tory activities acquired in vivo (25), as well as late-stage, normal
HBE cells exposed to bacterial and inflammatory factors from
CF airways, that is, sterile supernatants of mucopurulent material
(SMMs), to search for conductive and vesicular mechanisms that
mediate increased ATP release consequent to inflammation.
MATERIALS AND METHODS
Cell Culture
Primary HBE cell cultures established from surgical specimens from
healthy or CF donors were provided by theCystic Fibrosis Center Tissue
Culture Core Laboratory at the University of North Carolina, and grown
on 12-mm-diameter Transwell supports, as described elsewhere (26).
Cultures became confluent after 3–6 days and were subsequently grown
at an air–liquid interface for either 6–11 days (early stage, undifferentiated)
or 28–35 days (late stage, fully differentiated).
Supernatants of Mucopurulent Material
from CF Airways
The SMM was isolated from the lumens of chronically bacterially
infected and inflamed CF lungs, as previously described (27). SMM
or vehicle (PBS) (35 ml) was applied to the mucosal surface of cultures
for 48 hours in most experiments, but for 60 hours in a single series of
experiments, as indicated, and rinsed and used for ATP release or other
relevant measurements, as described.
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Cytokine Measurement
IL-8 was measured in the serosal medium, as described elsewhere (27).
Real-Time ATP Measurements
Cultures were rinsed and exposed to 100ml mucosal buffer, namely, Hank’s
balanced salt solution buffered with 10 mM HEPES, pH 7.4 (HBSS/
HEPES). After 1 hour, cultures were transferred to a Turner TD-20/20
luminometer (Turner Biosystems, Sunnyvale, CA), and luciferase and lu-
ciferin were added to the mucosal surface. Baseline luciferin/luciferase
activity was recorded, and cells were challenged with 50 ml hypotonic
(H2O) or isotonic (saline) solutions supplemented with 1 mM CaCl2
and 1 mM MgCl2, and ATP concentrations were determined in real
time, as previously described (19).
Uptake of Propidium Iodide
Cultures were challenged for 5 minutes with hypotonic solution (or
isotonic control), as already described, in the presence of 20 mM
propidium iodide (28). At the end of the incubation, the bathing
solution was replaced with HBSS containing 4% paraformalde-
hyde. The acquisition of confocal images and the quantification
of stained nuclei were performed using a Leica SP5 confocal mi-
croscope (Leica Microsystems, Buffalo Grove, IL), as previously
described (28).
Measurement of Adenyl Purines
Cultures were rinsed and preincubated for 1 hour with 300 ml mucosal
HBSS, after which 100 ml were removed for baseline nucleotide
measurements. One hundred microliters of H2O or saline (contain-
ing 1 mM CaCl2 and 1 mM MgCl2) were added to the mucosal fluid,
and aliquots were sampled after 30 seconds or 2 minutes. Adenine-
containing species were measured by etheno-derivatization, as de-
scribed elsewhere (29).
RT-PCR Analysis
Total RNAwas isolated using theRNeasy kit (Qiagen, Inc., Valencia, CA),
and was reverse-transcribed into cDNA using Superscript (Invitro-
gen, Carlsbad, CA). Primers used for the PCR amplification of vesic-
ular nucleotide transporter (VNUT) and pannexin 1 were described
elsewhere (20, 30). Amplified PCR products were identified by se-
quence analysis at the DNA sequencing facility of the University of
North Carolina at Chapel Hill. Quantitative PCR was performed as
previously described (22).
RhoA Pulldown Assay
Measurements of GTP-bound Rho-A were performed as previously de-
scribed (22).
Mucin Secretion Measurements
Mucin secretion was assessed by ELISA, using University of North
Carolina-230 rabbit polyclonal anti-mucin common subunit antibody, as
previously described (24).
Materials
All reagents were of the highest purity available, and were obtained
from sources previously described (20, 23, 24, 31).
Statistical Analysis
All experiments were performed on cultures established from at least
three different donors. Data were expressed as mean values 6 SEMs
or SDs, as indicated. Where appropriate, data were analyzed accord-
ing to an unpaired Student t test or ANOVA, using GraphPad InStat
software (GraphPad, La Jolla, CA). Statistical significance was defined
as P , 0.05.
RESULTS
Inflamed CF HBE Cells Exhibit Enhanced Hypotonicity-Evoked
ATP Release
Reflecting the chronically infected and inflamed milieu of the
donor lung (25), “younger” early-stage CF HBE cultures
(6–11 d old) exhibited a hyperinflammatory phenotype, as indicated
by increased baseline IL-8 secretion compared with normal HBE
cultures (Figure 1A, left). In contrast, IL-8 secretion rates were no
different from normal values in “older” late-stage CF cultures (28–
35 d old) (Figure 1A, right), indicating that the inflamed features of
CF airways were not retained in CF HBE cells in prolonged culture,
as previously shown (25). Baseline ATP levels were in the low
nanomolar range (1–2 nM), and were not different between control
and CF HBE cells, irrespective of culture age (Figure 1B). As pre-
viously reported, cells exposed to an apical hypotonic challenge (to
induce cell swelling–promoted ATP release) (19, 20) exhibited a ro-
bust, rapid (30 s) increase in ATP release (Figure 1B). Importantly,
peak levels of ATP release in response to hypotonicity reached the
micromolar range, and were significantly higher in young (6- to 11-d-
old) CF HBE cells relative to normal HBE cells of the same age
(Figure 1B, left). Similar to IL-8 values, differences in hypotonicity-
promoted ATP release between CF and normal HBE cells disap-
peared by 28–35 days in culture for CF HBE cells (Figure 1B,
right). These results indicate that young cultures of CF airway
epithelial cells exhibit an enhanced hypotonicity-induced nucle-
otide release that is associated with increased inflammation.
Influence of the CF Environment on Airway Epithelial
Nucleotide Release and Metabolism
Previously, we showed that the exposure of fully differentiated
cultures of normal or CFHBE cells to the influence of the in vivo
Figure 1. Inflamed cystic fibrosis human bronchial epithelial (CF HBE)
cells display increased hypotonicity-evoked ATP release. IL-8 secretion
(A) and hypotonicity-promoted ATP release (B) were assessed in pri-
mary CF HBE cultures grown for 6–11 days and 28–35 days. Hypoto-
nicity was applied at time ¼ 0, as indicated by the arrow. *Significant
difference (P , 0.05) from normal cultures. Values represent the
means 6 SEMs of four Transwells/subject, established from three dif-
ferent subjects.
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environment in the CF airway (i.e., SMMs isolated from CF
airways) produced an inflammatory phenotype, namely, the en-
hanced secretion of IL-8 (25). To investigate the possible asso-
ciation between airway epithelial cell inflammation and ATP
release, fully differentiated normal HBE cell cultures were
exposed for 48 hours to SMMs, and IL-8 secretion and ATP
release were measured both immediately upon SMM removal
and 14 days after removal. As previously reported (25), HBE
cells exhibited enhanced IL-8 secretion upon SMM exposure
(Figure 2A, left), whereas IL-8 secretion rates measured 14 days
later had returned to normal values (Figure 2A, right). Peak
ATP concentrations in response to hypotonic challenge signifi-
cantly increased (z70%) immediately after SMM treatment
(Figure 2B, left), but ATP levels returned to normal values after
14 days (Figure 2B, right). A similar increase in hypotonicity-
promoted ATP release was observed with SMM-treated (com-
pared with untreated) well-differentiated (WD)–HBE cells
isolated from subjects with CF (76% 6 27% increase, n ¼ 2).
Thus, during a 48-hour exposure to SMM, fully differentiated cul-
tures of both normal and CF HBE cells transiently acquired the
enhanced ATP release phenotype that characterizes the inflamed
CF HBE cells at early culture stages.
Airway epithelial cells express ectonucleotidase activities that
rapidly metabolize ATP to ADP, adenosine 59-monophosphate
(AMP), and adenosine (32). To assess the influence of SMM treat-
ment on the pattern of nucleotide/nucleoside distribution after
hypotonic challenge, the entire spectrum of adenine nucleotides/
nucleosides in ASL was quantified using the etheno-derivatization
technique (4). Resting concentrations of ADP, AMP, and adeno-
sine measured in the bulk solution bathing the apical culture sur-
faces (t ¼ 0) were markedly higher than ATP concentrations
(Figures 3A and 3B), and resting ATP/ADP/AMP levels did not
differ significantly between SMM-exposed and vehicle-exposed
normal HBE cells (Figure 3A). Consistent with the luminometry
data (Figure 2B), the exposure of cells to hypotonicity for
30 seconds robustly increased ATP levels, and this increase was
greater in SMM-treated cultures relative to control cultures (Fig-
ure 3A). ADP and AMP levels also were markedly higher in
hypotonically challenged, SMM-treated cells relative to vehicle-
treated HBE cells (Figure 3A). This finding suggests that ATP
was partly dephosphorylated upon release after hypotonic chal-
lenge. At 2 minutes after hypotonicity, levels of ATP and ADP
relaxed toward baseline levels, and were no longer different in
SMM-treated and vehicle-treated HBE cells. In contrast, AMP
levels continued increasing in SMM-treated cells (Figure 3A).
Unlike nucleotides, baseline adenosine levels in ASL after
SMM treatment exhibited an approximately 50% reduction rel-
ative to control cultures, and remained lower (in SMM-treated
cultures) after hypotonicity (Figure 3B). This reduction could
reflect the down-regulation of AMP-metabolizing enzymes (e.g.,
CD73 and alkaline phosphatase) (33) and/or the up-regulation of
adenosine degradation/uptake (34) in SMM-inflamed cells. De-
spite the adenosine reduction, the mass of the entire purine pool
increased significantly in ASL from SMM-treated HBE cells at
30 seconds and 120 seconds after hypotonicity (Figure 3C).
Collectively, these data suggest that the incubation of fully
differentiated HBE cells with SMM resulted in (1) the up-regulation
of the process involved in the release of ATP from hypotonicity-
stimulated HBE cells, and (2) the stimulation of processes that
reduced adenosine levels.
SMM Up-Regulates a Vesicular Nucleotide Release Pathway
Next, we asked whether the increased ATP release associated
with SMM treatment reflected a regulated mechanism, as op-
posed to enhanced plasma membrane fragility. Recently, we
have shown that Rho and Rho kinase activation are obligatory
steps regulating ATP release in airway epithelial cells, regardless
of the release pathway (exocytotic or conductive) (20, 22, 23).
Consistent with these observations, hypotonic stress promoted
enhanced Rho-A–GTP formation in vehicle-treated HBE cells
(Figure 4A). Rho-A activation was significantly, although mod-
estly, increased in SMM-treated relative to vehicle-treated HBE
cells under both isotonic and hypotonic conditions (Figure 4A).
Importantly, the potent and selective Rho kinase inhibitors
H1152 or Y27632 reduced hypotonicity-evoked ATP release
in control HBE cells, and nearly abolished the enhanced ATP
release that characterized SMM-treated HBE cells (Figure 4B).
These data suggest that the increased ATP release associated
with SMM treatment is regulated by Rho/Rho kinases.
ATP release from normal, ciliated cell–dominated airway
epithelia has been associated with the Rho-A–dependent open-
ing of the plasma membrane-channel pannexin 1 (Panx1) (20, 35).
In addition, goblet cell–rich epithelia display Rho-dependent,
Ca21-regulated, exocytotic ATP release, which has been asso-
ciated with mucin granule secretion (23, 36). Therefore, the con-
tributions of both Panx1 and Ca21-regulated vesicular pathways
to the enhanced ATP release associated with SMM treatment
were examined.
As predicted (20), resting cultures of vehicle-treated HBE cells
displayed negligible nuclear labeling with propidium iodide
(a pannexin conductance fluorescence probe), and the exposure
of cells to hypotonic challenge resulted in enhanced uptake of
the dye, which was nearly abolished by the Panx1 inhibitor
Figure 2. Enhanced ATP release from normal well-differentiated (WD)–
HBE cells exposed to the supernatants of mucopurulent material from
human CF airways (SMM). Normal cultures of WD-HBE cells were ex-
posed luminally to SMM (or vehicle) for 48 hours. Cells were rinsed,
and interleukin-8 secretion (A) and hypotonicity-promoted ATP release
(B) were assessed 1 hour or 14 days after the termination of SMM/
vehicle exposure. ATP release data represent the peak ATP concentra-
tions after hypotonic challenge. The data represent the mean 6 SEM of
four Transwells/subject established from three different subjects. *Sig-
nificant difference (P , 0.05). Hypo, hypotonic; Iso, isotonic.
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carbenoxolone. No differences in basal and hypotonicity-
stimulated propidium iodide uptake were observed between
control and SMM-treated cells, and carbenoxolone also nearly
abolished hypotonicity-promoted dye uptake in SMM-treated
cells (Figure 5A, left). Furthermore, carbenoxolone greatly
reduced (up to 25%) the release of ATP from noninflamed
HBE cells in response to hypotonic challenge, but the effect
of SMM on hypotonic stress–evoked ATP was mostly insensi-
tive to carbenoxolone (Figure 5A, right). Thus, SMM-inflamed
HBE cells display a robust Panx 1–independent component
mediating hypotonicity-promoted ATP release.
PCR analysis indicated no differences in Panx 1 mRNA
expression in control versus SMM-treated normal WD-HBE
cells, but a 6-fold increase in the level of expression for the vesicular
nucleotide transporter VNUT was observed after SMM treatment
(Figure 5C, left). Similar to normal WD-HBE cells, 28-day-old CF
HBE cells exposed to SMM exhibited enhanced VNUT (but not
pannexin 1) mRNA expression, relative to vehicle-treated cells
(Figure 5C, center). The increased expression of VNUT mRNA
in SMM-treated WD-HBE cells suggests that vesicular pathways
for airway epithelial ATP release are up-regulated in inflamed
CF lungs. Consistent with this hypothesis, early-stage CF cells
that retained the inflamed phenotype of in vivo CF airways, as
shown in Figure 1 and described previously by Ribeiro and col-
leagues (25), exhibited enhanced VNUT mRNA expression rela-
tive to fully differentiated (28-day-old) CF cell cultures (Figure 5C,
right).
Our previous studies indicated that the Ca21 chelator 1,2-bis
(2-amino-pheoxy)ethane-N,N,N9,N9-tetraacetic acid (BAPTA)
effectively abolished the Ca21 mobilization response to hypo-
tonic stress in normal HBE cells. However, BAPTA only mod-
estly reduced ATP release (z 10% inhibition) from these cells
(19), suggesting that Ca21-dependent vesicle exocytosis
provides only a minor contribution to ATP release in primary
cultures of normal HBE cells. In line with these observa-
tions, the preincubation of vehicle-treated HBE cells with
BAPTA–acetoxymethyl ester (AM) only modestly decreased
(10–20%) ATP release from vehicle-exposed cells in response to
hypotonicity (Figure 6). In contrast, the ATP release from SMM-
treated cells was markedly reduced (up to 50%) by BAPTA-AM.
Indeed, BAPTA practically abolished the component of ATP
release that was up-regulated by SMM treatment (Figure 6). In
addition, reagents that disrupt the secretory pathway (nocoda-
zole, brefeldin A, N-ethylmaleimide, and bafilomycin A1) mark-
edly reduced ATP release from SMM-inflamed cells, whereas
they exerted little effect on vehicle-treated cells (Figure 6).
Our recent studies with goblet-cell models revealed that nucleo-
tides are released as co-cargo molecules with mucins via Ca21-
regulated exocytosis (23). Therefore, the exocytotic mechanism of
ATP release that is up-regulated in SMM-inflamed HBE cells
may reflect an increased secretion of mucin granules in response
to hypotonicity. Our present findings, however, do not support this
hypothesis. In contrast to its effects on ATP release, hypotonicity
did not initiate mucin secretion from vehicle-treated HBE cells
(Figure 7). Previously, we reported that the exposure of primary
cultures of HBE cells to SMM increased the number of goblet cells
within the culture (37). As shown in Figure 7, despite a doubling of
ASL mucin secretion from resting (isotonic) cells after a 60-hour
exposure to SMM, hypotonicity did not promote mucin secretion
from these cultures (Figure 7). These results suggest that mucin
Figure 3. Changes in extracellular adenyl purines in SMM-treated normal
HBE cells. WD-HBE cell cultures exposed luminally to vehicle or SMMwere
assayed for extracellular ATP, ADP, and adenosine 59-monophosphate
(AMP) (A), and adenosine (B). Total adenyl species are shown in C.
Mucosal samples were collected under resting condition (t ¼ 0), 30
seconds (30"), or 2 minutes (120") after hypotonic challenge. The
values represent the means 6 SEMs of four Transwells/subject estab-
lished from three different subjects. *P , 0.05 and yP , 0.05, signif-
icant difference relative to time-matched and vehicle-exposed control
values and baseline values (T ¼ 0), respectively.
Figure 4. Involvement of Rho/Rho kinase in ATP release. (A) Normal
WD-HBE cells treated with vehicle or SMM for 48 hours were luminally
exposed to isotonic (Iso) or hypotonic (Hypo) solutions for 5 minutes,
and Rho-A was assessed as described in MATERIALS AND METHODS. The
Western blot (left) is representative of three independent experiments,
the quantification of which is illustrated on the right. yP , 0.005,
significantly different relative to vehicle. (B) Changes in hypotonicity-
promoted ATP release were measured in cells pretreated for 30 minutes
in the absence (Control) or presence of 1 mMH1152 or 10 mM Y27632.
yP , 0.05 and *P , 0.05, significantly different relative to vehicle and
control, respectively (mean 6 SEM, n ¼ 3).
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granules did not contribute to the increased ATP release observed
in vehicle-treated or SMM-inflamed airway epithelia.
DISCUSSION
Previous studies reported a correlation between adenine nucleotide/
nucleoside levels in vivo in ASL and neutrophil counts in airway
lavages from inflamed CF lungs (17). However, the contribution
of airway epithelial cells to lung inflammation–associated nucle-
otide release has only begun to be addressed (24). The major
finding of the present study is that airway epithelial cell cultures
exhibiting inflammatory responses relevant to CF up-regulate
their capacity to release ATP via vesicular pathways.
Two in vitro models of CF airway inflammation were used in
this study: (1) young (6- to 11-d-old, undifferentiated) primary
cultures of HBE cells from CF donors, which maintain the inflamed
phenotype characteristic of the chronically infected donor lung (25,
27), and (2) older (28- to 35-d-old), well-differentiated normal HBE
cells that were exposed in vitro to the infectious and inflammatory
milieu (SMM) from CF lungs (25). In both models, increased IL-8
secretion (an index of inflammation) was accompanied by an en-
hanced release of ATP in response to a hypotonic challenge. These
findings are consistent with reports indicating a link between ATP
release and inflammation, for example, in bladder urothelium
during interstitial cystitis (38), in colorectum epithelium dur-
ing colitis (39), and in vein endothelial cells after exposure to
LPS (40).
Our study also provides mechanistic insights into the pro-
cesses mediating the increased release of ATP associated with
inflammation. First, the enhanced release of ATP observed in
SMM-treated cultures reflects a regulated mechanism associ-
ated with Rho/Rho kinase activation, a key signaling pathway
that controls cytoskeletal rearrangements. The modest, but
significant, increase of Rho-A activity in SMM-treated cells,
together with the robust inhibitory effects of Rho kinase
inhibitors, suggest that the SMM-associated enhanced ATP
release is driven by the insertion of components of the ATP re-
lease machinery into the plasma membrane (20, 22, 23, 41). Sec-
ond, SMM-treated cultures exhibited a robust Ca21-dependent
(i.e., BAPTA-sensitive) ATP release that was inhibited by
reagents that disrupt the secretory pathway, such as brefeldin A,
nocodazole, N-ethylmaleimide (inhibitors of vesicle trafficking),
and bafilomycin A1 (an inhibitor of the vacuolar H
1/ATPase that
couples with VNUT to drive ATP transport into vesicles) (42–45).
In contrast, BAPTA and the inhibitors of the secretory pathway
exerted only a minor effect on ATP release from vehicle-treated
cells. Third, inhibition of the plasma membrane ATP channel
pannexin 1 markedly reduced the ATP release response in con-
trol HBE cells, but the increased ATP release associated with
SMM treatment was insensitive to pannexin 1 inhibition. Levels
of expression for pannexin 1 mRNA were similar in control and
inflamed HBE cell cultures, but VNUT transcripts were mark-
edly elevated in SMM-treated cells (Figure 5C). Collectively,
the data suggest that the increased ATP release observed in
inflamed HBE cultures reflects an up-regulation of vesicular
nucleotide release mechanisms.
Ca21-dependent vesicular nucleotide release from airway epi-
thelia has been previously associated with mucin granule secretion.
For example, we have reported that primary cultures of WD-HBE
cells, induced to develop goblet-cell metaplasia (24), exhibited in-
creased nucleotide release compared with ciliated cell–dominated
HBE cells. We also reported that mucin granules isolated from
goblet-like Calu-3 cells (lung adenocarcinoma cells) stored ATP
Figure 5. SMM-promoted changes in ATP release (DATP) are not af-
fected by pannexin 1 inhibition. The effects of carbenoxolone (CBX;
100 mM) on hypotonicity-induced propidium iodide (PI) uptake (A)
and ATP release (B) in normal WD-HBE cells exposed to vehicle or
SMM were assessed as indicated in MATERIALS AND METHODS. The values
represent the means6 SEMs of three Transwells/subject established from
three different subjects. *P , 0.05 and yP , 0.05, significant difference
from time-matched, vehicle-exposed control values and basal values,
respectively. (C) Pannexin 1 (Panx1) and vesicular nucleotide transporter
(VNUT) mRNA levels were quantified in WD-HBE cell cultures obtained
from normal or CF donors (left and center). The graph on the right illus-
trates VNUTmRNA expression levels in untreated CF cells after 7 or 28 days
in culture. The data are expressed as means 6 SDs (n ¼ 3). *P , 0.05,
relative to vehicle.
Figure 6. SMM promotes the up-regulation of ATP release from the
secretory pathway. (A) Changes in peak ATP concentrations between
hypotonic versus isotonic exposures (DATP) are indicated for vehicle-
exposed (open bars) and SMM-exposed (solid bars) HBE cell cultures.
Cells were preincubated for the indicated times with 1,2-bis(2-amino-
pheoxy)ethane-N,N,N9,N9-tetraacetic acid–acetoxymethyl ester (BAPTA-
AM, 100 mM), nocodazole (Noco, 20 mM), brefeldin A (BFA, 40 mM),
N-ethylmaleimide (NEM) (1 mM), or bafilomycin A1 (Bafi, 2 mM), as
previously described (24, 36). Values are expressed as the means 6
SDs of three Transwells/subject, established from three different sub-
jects. *P , 0.05 and **P , 0.01, significant difference relative to
control values. yP , 0.05, significant difference between vehicle-ex-
posed versus SMM-exposed cultures undergoing the same treatment.
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(23), and that stimuli that triggered mucin granule secretion from
these cells also promoted increased ATP release (23, 30, 36). Thus,
mucin granules are an important source of the ASL nucleotides
necessary to promote fluid secretion for mucin hydration.
However, our present study indicates that hypotonicity-evoked
ATP release fromeither vehicle-treated or SMM-treatedHBE cells
is not accompanied by increased mucin secretion (Figure 7).
Instead, our data suggest a previously unrecognized, mucin gran-
ule secretion–independent mechanism of nucleotide release from
a vesicular secretory pathway in HBE cells. Interestingly, Ca21-
regulated nucleotide release from unidentified vesicular pools has
been recently reported with other tissues lacking biochemically
or morphologically defined secretory granules, such as T-cell
receptor–stimulated lymphocytes (43), hypotonically stimulated
rat hepatoma cells (46) and cholangiocytes (47), and lung carci-
noma A549 cells (48, 49). Moreover, recent cell-fractionation stud-
ies using the airway epithelial Calu-3 cell line indicated that VNUT
sedimented not only with the mucin granule–rich fraction, but also
with mucin-free vesicles associated with the lysosome-rich and en-
doplasmic reticulum/Golgi-rich fractions (30). Immunofluorescence
analysis of Calu-3 cells overexpressing Myc-tagged VNUT indi-
cated Myc–VNUT localization to vesicles devoid of mucins, in
addition to mucin granules (30). Given these observations and
reports that VNUT is involved in the storage and release of ATP
from orphan vesicles in a number of cell types (43, 47, 50), we
hypothesize that a VNUT-dependent, ATP-loaded vesicular pool,
different from the pool associated with mucin granules, contributed
to the enhanced ATP release observed in inflamed HBE cells.
In conclusion, our study demonstrates that airway epithelial cells
exposed to inflammatory conditions relevant to CF-diseased lungs
exhibit enhanced vesicular ATP release in response to hypotonic
cell swelling. Given the reported action of nucleotides on inflamma-
tory cell motility and the abundance of purinergic receptors in
inflammatory and immunocompetent cells (51), the up-regulation
of ATP release by inflamed airway epithelia may perpetuate
the inflammatory phenotype.
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